Recent advancements have highlighted new targets for the extracellular matrix protein fibronectin (FN) and its extra-domain B (EDB-FN), which are expressed in fetal and cancerous tissues, making them useful for targeted radioisotope delivery in cancers, including TC. Here, FN1 is linked to cancer.